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Background: There is a paucity of data on the outcome of contemporary percutaneous coronary intervention
(PCI) in the elderly. Accordingly, we assessed the impact of age on outcome of a large cohort of patients
undergoing PCI in a regional collaborative registry.
Hypothesis: Increasing age is associated with a higher incidence of procedural-related complications.
Methods: We evaluated the outcome of 152 373 patients who underwent PCI from 2003 to 2008 in the 31
hospitals participating in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. The procedural
outcomes of the cohort were compared by dividing patients into <70 years of age, 70 to 79 years, 80 to
84 years, 85 to 89 years, and ≥90 years.
Results: Of the cohort, 64.64% were <70 years of age, 23.83% were 70 to 79 years, 7.85% were 80 to
84 years, 3.09% were 85 to 89 years, and 0.58% were 90 years or older. Increasing age was associated with
an increase in all-cause in-hospital mortality, contrast-induced nephropathy, transfusion, stroke/transient
ischemic attack, and vascular complications. The overall in-hospital mortality rate was 1.09% and increased
from 0.67% in those younger than 70 years up to 5.44% in those 90 years old or greater. The mortality rate in
patients over 80 years approached 12% to 15% for those with ST-segment myocardial infarction and 39% in
cardiogenic shock patients.
Conclusions: Theproportion of elderly patients referred for PCI is increasing. Procedural complications increase
with age, and patients presenting with unstable symptoms are at the highest risk.
Introduction
The elderly are the most rapidly growing segment of the
population in the western world.1,2 Coronary artery disease
prevalence rises with age, and coronary revascularization
is commonly performed in elderly patients for treatment.3
Prior studies have demonstrated a 2- to 4-fold higher risk
of mortality and major complications in elderly patients
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undergoing percutaneous coronary interventions (PCI).4
Most of these studies are almost a decade old and
may not reflect contemporary outcomes. Advances in
technology, optimization of pharmacotherapy, and better
risk stratification are associated with a decline in procedural
complications over the past decade.
There is a paucity of data on outcome of contemporary
PCI in the elderly. Accordingly, we assessed the impact of
age on outcome of a large cohort of patients undergoing
PCI in a regional collaborative registry.
Methods
The study cohort included patients undergoing PCI be-
tween 2003 and 2008 in a regional PCI registry. The details
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of the Blue Cross Blue Shield of Michigan Cardiovascular
Consortium registry and the data collection process have
been described elsewhere.5–9 Briefly, procedural data on
all patients undergoing PCI at the 31 participating hospitals
were collected using standardized collection forms. Baseline
data included clinical, demographic, procedural, and
angiographic characteristics; as well as medications used
before, during, and after the procedure; and in-hospital
outcome. All data elements had been prospectively defined
and the local institutional review board approved the
protocol. A dedicated staff member collected the data and
forwarded it to the coordinating center. Medical records
of all patients undergoing coronary artery bypass grafting
(CABG), and of patients who died in the hospital were
reviewed by auditors from the coordinating center to
ensure accuracy. A further 2% of cases were randomly
selected for audit. All procedures were performed using
standard coronary intervention techniques. The choice of
medications as well as equipment was at the discretion of
the operating physician.
Procedural outcomes of the cohort were compared by
dividing patients into <70 years of age, 70 to 79 years, 80
to 84 years, 85 to 89 years, and ≥90 years. The primary
endpoint was in-hospital death. Other endpoints included
postprocedure transfusion, contrast-induced nephropathy,
stroke/transient ischemic attack (TIA), and vascular
complications. In-hospital death was defined as death
from either cardiac or noncardiac cause. Blood transfusion
was defined as any transfusion of product regardless of
the number of units transfused. Vascular complication
was defined as: pseudoaneurysm, arteriovenous fistula,
femoral neuropathy, retroperitoneal hematoma, access
site hematoma requiring transfusion/prolonged hospital
stay or causing a drop in hemoglobin >3.0 gm/dL, or any
access site complication requiring surgical repair. Because
the risk of complications is influenced by procedural
indications, we evaluated complications by key indications:
cardiogenic shock, primary PCI for ST-segment myocardial
infarction (STEMI), and stable PCI. Stable patients were
defined as those requiring nonurgent PCI, and excluded
patients with presenting cardiogenic shock or cardiac
arrest, those with a myocardial infarction (MI) within the
preceding 7 days, and those who received intravenous
heparin or nitrates, low-molecular weight heparin, or a GP
IIbIIIa inhibitor before the procedure.
Statistical Analysis
Continuous variables were expressed as mean ± standard
deviation, and discrete variables were expressed as
frequency counts and percentages. The difference in
variable frequency between groups was evaluated by the
Mantel-Haenszel χ2 test. Trends over age groups were
evaluated by the Cochran-Armitage test.
Results
Baseline Demographics
The baseline demographics of the 152 373 patients are
listed in the Table 1. Of the total cohort, 64.64% were
<70 years of age, 23.83% were 70 to 79 years, 7.85% were
80 to 84 years, 3.09% were 85 to 89 years, and 0.58% were
90 years or greater. The proportion of patients in each
age group remained stable throughout the study period.
Stable patients accounted for 63 876 patients, whereas
20 220 underwent PCI for STEMI. Older patients were
more likely to be female, lean (body mass index <25),
and nonsmokers. Older patients were also more likely to
suffer from medical comorbidities, but less likely to have
diabetes, renal failure with dialysis, or to have sustained a
previous cardiac arrest. There was no difference among the
groups in having a prior PCI.
Clinical Outcomes
All-cause in-hospital mortality rate was 1.09% and increased
with age (P < 0.0001). The overall mortality for PCI was
0.67% in those younger than 70 years, 1.43% in those 70
to 79 years, and increased to 5.44% in those 90 years or
greater (Figure 1). Increasing age was also associated with
higher rates of contrast-induced nephropathy, transfusion,
stroke/TIA, and vascular complications in all cases. In
the cohort of patients, emergency coronary surgery was
required in 565 (0.37%) patients. The rate of unplanned
or emergency CABG was not related to age and occurred
in 379 (0.38%) patients younger than 70 years, 124 (0.37%)
patients 70 to 79 years, 43 (0.36%) patients 80 to 84 years,
14 (0.30%) patients 85 to 89 years, and 5 (0.57%) patients
90 years or greater (trend, P = 0.38). The overall rate of
contrast-induced nephropathy was 2.83% and as high as
9.33% in those 90 years or older (Figure 2). Transfusion was
required in 4.96% of all patients in the study, with 3.54%
in those younger than 70 years and increasing to 14.2% in
those 90 years or greater (Figure 3). The rate of stroke/TIA
increased from 0.23% in patients younger than 70 years, up to
0.91% in patients 90 years or greater (Figure 4). Increasing
age was also associated with a higher rate of vascular
complications. The overall rate of vascular complications in
the cohort was 2.43% and increased from 2.05% in patients
younger than 70 years, up to 4.08% in patients 90 years or
greater (Figure 5).
Subgroup analysis of stable patients and patients with a
STEMI demonstrated that increasing age was associated
with higher rates of death, contrast-induced nephropathy,
transfusion, stroke/TIA, and vascular complications in both
subgroups (Figures 1–5). In stable patients, the mortal-
ity rate increased from 0.07% in patients younger than
70 years to 1.34% in patients 90 years or greater, P < 0.0001
(Figure 1). Rates of contrast-induced nephropathy, trans-
fusion, stroke/TIA, and vascular complications in stable
patients followed similar trends, P < 0.0001 in all cases
(Figures 2–5). The overall mortality rate in STEMI patients
was 4.50; with 2.75% in those younger than 70 years, 7.85%
in those 70 to 79 yeras, 11.82% in those 80 to 84 years,
14.04% in those 85 to 89 years, and 14.19% in those 90 years
or older (trend, P < 0.0001 [Figure 1]). Contrast-induced
nephropathy rates increased from 4.88% in patients younger
than 70 years to 17.16% in 90 year olds or greater (trend,
P < 0.0001 [Figure 2]). Transfusion rates, stroke/TIA rates,
and vascular complication rates also followed similar trends
(trend, P < 0.0001 in both cases [Figures 3–5]).
As expected, complication rates in patients presenting
with cardiogenic shock was much higher than those without,
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Table 1. Baseline Demographics and Clinical Variables
<70 70–79 80–84 85–89 90+
N= 98 500 N= 36 318 N= 11 966 N= 4707 N=882 Trend P
Demographic % % % % %
Female 28.83 41.64 47.97 53.28 58.62 <0.0001
Current smoking 36.02 10.96 5.16 3.02 3.06 <0.001
Lean, BMI <25 14.3 21.82 33.5 43.54 53.33 <0.0001
Obese, BMI >30 52.17 38.45 25.09 17.32 12.86 <0.0001
Overweight, BMI 25–30 33.56 39.75 41.49 39.2 33.93 <0.0001
Historical
Hypertension 78.27 86.75 88.52 88.95 87.76 <0.0001
MI 33.99 35.97 36.18 37.01 37.87 <0.0001
Diabetes 34.41 37.22 32 25.98 22.79 <0.0001
CHF 10.69 18.59 23.59 27.62 30.95 <0.0001
Extracardiac vascular disease 19.24 33.23 38.17 39.71 36.39 <0.0001
Renal failure w/dialysis 2.04 2.03 1.86 1.1 0.57 <0.0001
Significant valve disease 2.7 6.12 9.01 10.43 12.13 <0.0001
GI bleeding 1.43 2.65 3.54 3.55 4.08 <0.0001
AFib 5.36 14.57 19.71 23.18 22 <0.0001
Cardiac arrest 1.35 1.23 1.06 1.27 0.45 0.002
Prior PCI 42.63 44.42 43.28 42.07 39.57 0.08
CABG 15.88 27 26.75 22.31 15.42 <0.0001
COPD 16.78 21.49 20.09 19.38 15.76 <0.0001
Laboratory
Baseline Hgb, mean, g/dL (SD) 13.9 (1.83) 13.1 (1.79) 12.6 (1.84) 12.3 (1.70) 12.1 (1.63) <0.0001
WHO anemia 22.32 36 46.04 52.33 54.99 <0.0001
Baseline Cr, mean, mg/dL (SD) 1.16 (1.05) 1.24 (1.01) 1.27 (1.19) 1.27 (0.63) 1.26 (0.42) <0.0001
Baseline Cr >1.5, mg/dL 8.36 15.78 20.67 23.28 24.72 <0.0001
EF, mean (SD) 52.0 (11.5) 51.4 (12.2) 49.7 (12.7) 48.7 (12.8) 47.6 (13.1) <0.0001
EF <50% 28.31 31.54 39.02 43.85 46.49 <0.0001
Abbreviations: AFib, atrial fibrillation; BMI, body mass index; CABG, coronary artery bypass grafting; CHF, congestive heart failure; COPD, chronic
obstructive pulmonary disease; Cr, creatinine; EF, ejection fraction; GI, gastrointestinal; Hgb, hemoglobin; MI, myocardial infarction; PCI, percutaneous
coronary intervention; SD, standard deviation; WHO, World Health Organization.
with the mortality rate increasing from 33% in patients 70 to
79 years of age, with shock to nearly 50% in those 90 years
old or greater (Figures 1–5).
Discussion
The elderly account for a large proportion of patients
undergoing PCI. This population has been shown to have
an increased incidence of PCI-related complications. The
present study supports these findings and demonstrates
that the procedure can be performed with a reasonable
degree of safety with relatively low associated morbidity
and mortality in stable patients. However, the rate of
complications increases in high-risk groups. The current
study offers a contemporary view of current practice and
complication rates with patients having been treated from
2003 to 2008, and to our knowledge, includes the 3rd largest
cohort of patients undergoing PCI over 80.10,11
Poor outcomes among the elderly undergoing PCI were
recognized in the early days of angioplasty. Studies prior
to the development of intracoronary stenting demonstrated
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Figure 1. Death by age group. Abbreviation: STEMI, ST-segment
myocardial infarction.
a mortality of approximately 8% to 20%,11–14 with many
being single-center experiences enrolling less than 60
octogenarians.12–14 With the advent of stenting, mortality
decreased.4,15,16 Two large multicenter registries examined
PCI-related complications in octogenarians between 1994
and 2000. Batchelor et al evaluated the outcomes of
7472 octogenarians from 1994 to 1997 in the National
Cardiovascular Network (NCN) and observed an in-hospital
mortality rate of 3.8%, whereas a 3.77% in-hospital mortality
rate was observed in the 8828 octogenarians in the
American College of Cardiology–National Cardiovascular
Disease Registry (ACC-NCDR) from 1998 to 2000.4,15
Singh et al found an overall mortality of 3.16% in 155 612
octogenarians in the NCDR registry from 2001 to 2006, with
a temporal decline in mortality during the study period.10
The mortality rate of 2.75% in the 17 555 patients 80 years
or greater in our study is probably a reflection of the
use of PCI in a slightly different population. In the NCN
registry, 9.7% of octogenarians were experiencing an acute
MI, whereas 68% of cases were elective, and similarly, in
the ACC-NCDR registry, 67.1% of octogenarians had not
experienced an MI within the preceding 7 days.4,15 In the
NCDR registry, 65% of octogenarians were experiencing an
acute coronary syndrome (34.89% unstable angina, 18.75%
Figure 3. Transfusion by age group. Abbreviation: STEMI, ST-segment
myocardial infarction.
Figure 4. Stroke/transient ischemic attack (TIA) by age group.
Abbreviation: STEMI, ST-segment myocardial infarction.
non-STEMI, and 11.35% STEMI).10 In the current study,
only 39.2% of the octogenarians were stable, whereas
10.9% were experiencing a STEMI. This may suggest that
although we are taking a larger group of unstable/high-risk
octogenarians for cardiac catheterization and intervention,
the mortality rates have remained acceptable.
Figure 2. Contrast-induced nephropathy (CIN) by age group. Abbreviation: STEMI, ST-segment myocardial infarction.
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Figure 5. Vascular complications by age group. Abbreviation: STEMI,
ST-segment myocardial infarction.
Stroke and contrast-induced nephropathy following PCI
are associated with higher morbidity and mortality.15,17,18
Although the rate of stroke increased across all age groups
in our study, the rate remained less than 1% for all patients
(Figure 4). This is in agreement with previous studies that
have documented a risk of 0% to 1.5% risk of stroke following
PCI.10,19–24 We also found that the rates of contrast-induced
nephropathy increased with age. Given that the elderly
inherently have a reduction in renal function, this calls
attention to the importance of limiting contrast to elderly
patients given the influence of contrast-induced nephropathy
on morbidity and mortality.
Vascular complication rates and need for postprocedure
transfusion demonstrated similar trends. Over the past
several years, there has been a change in antithrombotic
regimens used during and after PCI. However, the rates
observed in our study are similar to that of previous
findings.4,15,19,20 This may be secondary to the lack of
adjustment for differing pharmacokinetics and the in-
creased risk of vascular injury in elderly patients.
In stable patients, the risk of in-hospital death did not
exceed 1.5% across all age groups. Furthermore, the rates
of all complications studied are lower in this group of
patients. These low complications need to be balanced
in the context of outcomes associated with alternate
therapeutic strategies available, including medical therapy
and CABG. The benefit of PCI in elderly patients vs
medical therapy was evaluated in the Trial of Invasive
versus Medical therapy in Elderly patients (TIME) trial,
demonstrating that although an invasive approach was
associated with procedural risk and no survival benefit,
medical management was associated with a 50% chance
of subsequent hospitalization and revascularization.25
Further, a meta-analysis of revascularization strategies in
octogenarians demonstrated that the 30-day mortality for
PCI was less than that for CABG (5.4% vs 7.2%, respectively),
whereas 1-year survival was nearly equal (87% in PCI
and 86% in CABG).3 Furthermore, given the morbidity
associated with CABG, PCI is often preferred by elderly
patients. Therefore, based on the results of the current
study and prior studies that documented the benefits of
PCI vs optimized medical therapy or CABG, age alone
should not be a contraindication to the consideration
of cardiac catheterization with potential intervention in
symptomatic elderly patients. Further research needs to
be done to determine if revascularization vs contemporary
medical therapy is the appropriate management of
asymptomatic ischemia in elderly patients given the findings
of Asymptomatic Cardiac Ischemia Pilot Study (ACIP)
and Clinical Outcomes Utilizing Revascularization and
Aggressive Drug Evaluation (COURAGE).26,27
In STEMI patients, mortality approached 12% in patients
80 to 84 years old, and nearly 15% in patients age 85 years
and greater (Figure 1). This is similar to the outcomes of
PCI in octogenarians in the ACC-NCDR, where the mortality
rate was nearly 14% in those who presented with an acute MI
within 24 hours, and less than the 27% observed in-hospital
mortality in nonagenarians in a retrospective analysis.15,28
Despite the high mortality rate observed in this patient
group, it is much less than those patients treated medically
for STEMI or cardiogenic shock.29 Although in our registry,
the STEMI and cardiogenic shock populations had the high-
est rate of mortality and other procedure-related complica-
tions, we feel that this risk is appropriate given the morbidity
and mortality associated with medical therapy alone.
Limitations
The limitations of this study are similar to other
multicenter registries in that it offers observational data
on nonrandomized patients. In a PCI study of elderly and
very elderly patients, there may be a referral bias in that
healthier older patients are being referred to PCI. As PCI
complications and success are related to operator volume,
the study did not analyze the relationship of volume to
the rate of complications. Finally, the study does not include
patients who received medical or surgical (CABG) therapies.
Conclusion
The proportion of elderly patients referred for PCI is
increasing as this segment of the population continues to
grow. The complication rates from PCI increase with age,
and those with unstable symptoms have worse outcomes.
However, we feel these rates are acceptable given higher
complication rates with alternative strategies, and patient
selection for PCI is important. Therefore, age alone should
not be a contraindication to PCI.
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